{"id":246008,"date":"2016-09-06T06:59:22","date_gmt":"2016-09-06T06:59:22","guid":{"rendered":"http:\/\/citifmonline.com\/?p=246008"},"modified":"2016-09-06T06:59:22","modified_gmt":"2016-09-06T06:59:22","slug":"new-drug-to-control-type-2-diabetes-launched","status":"publish","type":"post","link":"https:\/\/citifmonline.com\/2016\/09\/new-drug-to-control-type-2-diabetes-launched\/","title":{"rendered":"New drug to control Type 2 diabetes launched"},"content":{"rendered":"
AstraZeneca, a Multi-National Pharmaceutical (Pty) Ltd operating in the country has introduced \u2018Forxiga (dapagliflozin) 10mg tablets\u2019, a new drug to control type 2 diabetes onto the Ghanaian market.<\/p>\n
Diabetes is said to be one of the rising killer diseases globally, claiming one life every eight seconds and a limb lost at every 30 seconds, according to reports from World Health Organisation and the International Diabetes Federation.<\/p>\n
Mr William Ofori, Country Manager of AstraZeneca in Ghana who launched the new medicine, said Forxiga is a prescription medicine used together with diet and exercise to lower blood sugar in adults 18 years and older with type 2 diabetes.<\/p>\n
He said it is the first medicine that works in the kidney to flush away excess sugar via urine and belongs to a class of medicines called SGLT2 (sodium-glucose cotransporter 2) inhibitors.<\/p>\n
Prince K Aryee, Product Specialist- CV\/Met of AstraZeneca in an interview with the Ghana News Agency said the medicine must be taken once daily anytime of the day with or without meals by prescription by a medical doctor.<\/p>\n
About Type 2 diabetes<\/strong><\/p>\n Type 2 diabetes was previously called non-insulin-dependent diabetes mellitus (NIDDM) or adult-onset diabetes. Type 2 diabetes may account for about 90 per cent to 95 per cent of all diagnosed cases of diabetes.<\/p>\n Risk factors for Type 2 diabetes include obesity, family history of diabetes, prior history of gestational diabetes, impaired glucose tolerance, physical inactivity.<\/p>\n Diabetes is caused by the failure of the \u201cpower-house\u201d of the cell to use glucose to produce energy. The \u201cpower-house\u201d is known as mitochondrial matrix.<\/p>\n People with diabetes fail to convert most of the glucose into energy. Hence, glucose builds up in the blood and passes out of the body as part of the urine.<\/p>\n Diabetes could cause serious health complications including heart diseases, blindness, kidney failure, and lower-extremity amputations.<\/p>\n In Ghana, about four million people may be affected with diabetes mellitus, which is a group of metabolic diseases in which a person has high blood sugar, a condition which could be attributed to a situation where either the body does not produce enough insulin or because cells do not respond to the insulin that is produced; but it could be controlled and managed with little injections of insulin.<\/p>\n –<\/p>\n Source: GNA<\/p>\n","protected":false},"excerpt":{"rendered":" AstraZeneca, a Multi-National Pharmaceutical (Pty) Ltd operating in the country has introduced \u2018Forxiga (dapagliflozin) 10mg tablets\u2019, a new drug to control type 2 diabetes onto the Ghanaian market. Diabetes is said to be one of the rising killer diseases globally, claiming one life every eight seconds and a limb lost at every 30 seconds, according […]<\/p>\n","protected":false},"author":14,"featured_media":246021,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[19],"tags":[],"yoast_head":"\n